Amberlyst-15 catalysed synthesis of novel indole derivatives under ultrasound irradiation : Their evaluation as serotonin 5-HT2C receptor agonists
Copyright © 2021 Elsevier Inc. All rights reserved..
A series of indole based novel Schiff bases was designed as potential agonists of 5-HT2C receptor that was supported by docking studies in silico. These compounds were synthesized via Amberlyst-15 catalysed condensation of an appropriate pyrazole based primary amine with the corresponding indole-3-aldehyde under ultrasound irradiation at ambient temperature. A number of target Schiff bases were obtained in good yields (77-87%) under mild conditions within 1 h. Notably, the methodology afforded the corresponding pyrazolo[4,3-d]pyrimidin-7(4H)-one derivatives when the primary amine was replaced by a secondary amine. Several Schiff bases showed agonist activity when tested against human 5-HT2C using luciferase assay in HEK293T cells in vitro. The SAR (Structure-Activity-Relationship) studies suggested that the imine moiety was more favorable over its cyclic form i.e. the corresponding pyrazolopyrimidinone ring. The Schiff bases 3b (EC50 1.8 nM) and 3i (EC50 5.7 nM) were identified as the most active compounds and were comparable with Lorcaserin (EC50 8.5 nM). Also like Lorcaserin, none of these compounds were found to be PAM of 5-HT2C. With ∼24 and ∼150 fold selectivity towards 5-HT2C over 5-HT2A and 5-HT2B respectively the compound 3i that reduced locomotor activity in zebrafish (Danio rerio) larvae model emerged as a promising hit molecule for further study.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:116 |
---|---|
Enthalten in: |
Bioorganic chemistry - 116(2021) vom: 01. Nov., Seite 105380 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Reddy, Gangireddy Sujeevan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 04.01.2022 Date Revised 04.01.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bioorg.2021.105380 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM332105504 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM332105504 | ||
003 | DE-627 | ||
005 | 20231225214918.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bioorg.2021.105380 |2 doi | |
028 | 5 | 2 | |a pubmed24n1106.xml |
035 | |a (DE-627)NLM332105504 | ||
035 | |a (NLM)34670330 | ||
035 | |a (PII)S0045-2068(21)00757-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Reddy, Gangireddy Sujeevan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Amberlyst-15 catalysed synthesis of novel indole derivatives under ultrasound irradiation |b Their evaluation as serotonin 5-HT2C receptor agonists |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.01.2022 | ||
500 | |a Date Revised 04.01.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
520 | |a A series of indole based novel Schiff bases was designed as potential agonists of 5-HT2C receptor that was supported by docking studies in silico. These compounds were synthesized via Amberlyst-15 catalysed condensation of an appropriate pyrazole based primary amine with the corresponding indole-3-aldehyde under ultrasound irradiation at ambient temperature. A number of target Schiff bases were obtained in good yields (77-87%) under mild conditions within 1 h. Notably, the methodology afforded the corresponding pyrazolo[4,3-d]pyrimidin-7(4H)-one derivatives when the primary amine was replaced by a secondary amine. Several Schiff bases showed agonist activity when tested against human 5-HT2C using luciferase assay in HEK293T cells in vitro. The SAR (Structure-Activity-Relationship) studies suggested that the imine moiety was more favorable over its cyclic form i.e. the corresponding pyrazolopyrimidinone ring. The Schiff bases 3b (EC50 1.8 nM) and 3i (EC50 5.7 nM) were identified as the most active compounds and were comparable with Lorcaserin (EC50 8.5 nM). Also like Lorcaserin, none of these compounds were found to be PAM of 5-HT2C. With ∼24 and ∼150 fold selectivity towards 5-HT2C over 5-HT2A and 5-HT2B respectively the compound 3i that reduced locomotor activity in zebrafish (Danio rerio) larvae model emerged as a promising hit molecule for further study | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a 5-HT(2C) receptor | |
650 | 4 | |a Agonist | |
650 | 4 | |a Indole | |
650 | 4 | |a Schiff base | |
650 | 4 | |a Ultrasound | |
650 | 7 | |a Indoles |2 NLM | |
650 | 7 | |a Receptor, Serotonin, 5-HT2C |2 NLM | |
650 | 7 | |a Serotonin 5-HT2 Receptor Agonists |2 NLM | |
650 | 7 | |a Styrenes |2 NLM | |
650 | 7 | |a amberlyst-15 |2 NLM | |
650 | 7 | |a indole |2 NLM | |
650 | 7 | |a 8724FJW4M5 |2 NLM | |
700 | 1 | |a Kamaraj, Rajamanikkam |e verfasserin |4 aut | |
700 | 1 | |a Hossain, Kazi Amirul |e verfasserin |4 aut | |
700 | 1 | |a Kumar, Jetta Sandeep |e verfasserin |4 aut | |
700 | 1 | |a Thirupataiah, B |e verfasserin |4 aut | |
700 | 1 | |a Medishetti, Raghavender |e verfasserin |4 aut | |
700 | 1 | |a Sushma Sri, N |e verfasserin |4 aut | |
700 | 1 | |a Misra, Parimal |e verfasserin |4 aut | |
700 | 1 | |a Pal, Manojit |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioorganic chemistry |d 1986 |g 116(2021) vom: 01. Nov., Seite 105380 |w (DE-627)NLM012846570 |x 1090-2120 |7 nnns |
773 | 1 | 8 | |g volume:116 |g year:2021 |g day:01 |g month:11 |g pages:105380 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bioorg.2021.105380 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 116 |j 2021 |b 01 |c 11 |h 105380 |